Kazumi Shiosaki

Kazumi Shiosaki, Ph.D., joined MPM in 2003. Her interests and expertise include identifying companies and technologies in novel drug discovery areas. Kazumi has helped to found and served as the start-up CEO of several MPM companies including Primera Diagnostics, Epizyme (EPZM), and most recently Mitobridge. She serves on the boards, as well as